Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.

Flavoured cigarette ban helps reduce smoking in youths

03 Sep 2020
The ongoing fight against tobacco industry has been a long and continuous effort.

A ban on flavoured cigarettes is an effective measure to curb cigarette use among young people, a recent study has found.

Researchers used data from the 2002–2017 National Survey on Drug Use and Health of the US (n=893,226). They looked at the changes in cigarette consumption patterns from before to after the ban on flavoured cigarettes came into effect on 22 September 2019.

The ban showed its greatest effect on young people. Among youth, aged 12–17 years, researchers recorded a 17-percent spike in the likelihood of reporting 30-day use of any cigarette immediately following the flavour ban (odds ratio [OR], 1.17, 95 percent confidence interval [CI], 1.07–1.29; p<0.001).

Young adults, aged 18–25 years, in comparison, saw a 9-percent immediate jump in the odds of reporting any cigarette use in the past 30 days (OR, 1.09, 95 percent CI, 1.03–1.16; p=0.0047).  No such immediate effect was reported for adults (26–49 years) and older adults (≥50 years).

Despite this initial increase, the overall effect of the ban was positive overall after considering the change in temporal change in behaviours over the 33 quarters after the flavour ban.

In 2017, for example, the youth age group was 43-percent less likely to smoke cigarettes, as compared to the predicted probability in the absence of the flavour ban. The same analysis showed that young adults were 27-percent less likely to smoke cigarettes. A similar signal was also reported for adults, who saw a drop in smoking probability of around 12 percent.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.